In Japan, an increasing interest in real-world evidence for hypothesis generation and
decision-making has emerged in order to overcome limitations and restrictions of clinical …

The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral
anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists …

目的: 探索影响心房颤动(房颤) 患者在使用华法林抗凝治疗过程中稳定性达标的因素,
以期为改善华法林的抗凝质量提供参考. 方法: 选取2019 年1 月—2019 年12 …

Introduction There are a paucity of real-world data examining effectiveness and safety of non-
vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial …

Background Although several studies have compared the effectiveness and safety of
rivaroxaban and apixaban in patients with venous thromboembolism (VTE), direct …

Background: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia type. Patients
with AF are often administered anticoagulants to reduce the risk of ischemic stroke due to an …

Background To overcome the several drawbacks of warfarin, non-vitamin K antagonist oral
anticoagulants (NOACs) were developed. Even though randomized controlled trials (RCTs) …

Background Non-valvular atrial fibrillation (NVAF) is the most common cause of cardiogenic
cerebral embolism (CCE). However, the underlying mechanism between cerebral embolism …

Objective To evaluate the efficacy and safety of oral anticoagulants for older adult patients
with atrial fibrillation (AF). Design Pairwise and network meta-analyses. Setting and …

Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …